First Streptococcus agalactiae isolates highly resistant to quinolones, with point mutations in gyrA and parC. - Wikidata - wikimedia - TriplyDB

First Streptococcus agalactiae isolates highly resistant to quinolones, with point mutations in gyrA and parC.

First Streptococcus agalactiae isolates highly resistant to quinolones, with point mutations in gyrA and parC.

http://www.wikidata.org/entity/Q36880109

about

Frequency of antimicrobial resistance among invasive and colonizing Group B streptococcal isolates.Genetic diversity and antimicrobial resistance in Streptococcus agalactiae strains recovered from female carriers in the Bucharest area.Characterization of multidrug-resistant group B streptococci with reduced penicillin susceptibility forming small non-Beta-hemolytic colonies on sheep blood agar plates.Fluoroquinolone-resistant Streptococcus agalactiae: epidemiology and mechanism of resistance.Horizontal gene transfer and recombination in Streptococcus dysgalactiae subsp. equisimilis Fluoroquinolone resistance in invasive Streptococcus pyogenes isolates due to spontaneous mutation and horizontal gene transfer.Emergence of the first levofloxacin-resistant strains of Streptococcus agalactiae isolated in Italy.Serotypes, antibiotic susceptibilities, and multi-locus sequence type profiles of Streptococcus agalactiae isolates circulating in Beijing, China.First characterization of fluoroquinolone resistance in Streptococcus suis.Antibiotic resistances of starter and probiotic strains of lactic acid bacteria.Significance, management and prevention of Streptococcus agalactiae infection during the perinatal period.Emergence of fluoroquinolone resistance in group B streptococcal isolates in Taiwan.High prevalence of fluoroquinolone-resistant group B streptococci among clinical isolates in China and predominance of sequence type 19 with serotype III.Genetic heterogeneity in pbp genes among clinically isolated group B Streptococci with reduced penicillin susceptibility.Fluoroquinolone-resistant group B streptococci in acute exacerbation of chronic bronchitis.Antibiotic susceptibility patterns and prevalence of group B Streptococcus isolated from pregnant women in Misiones, Argentina.Capsular type and antibiotic resistance in Streptococcus agalactiae isolates from patients, ranging from newborns to the elderly, with invasive infections.Molecular Characteristics of Group B Streptococci Isolated from Adults with Invasive Infections in Japan.Changing Epidemiology of Group B Streptococcus Susceptibility to Fluoroquinolones and Aminoglycosides in France.Fluoroquinolone Resistance among Clonal Complex 1 Group B Streptococcus Strains.Fluoroquinolone resistance in Streptococcus dysgalactiae subsp. equisimilis and evidence for a shared global gene pool with Streptococcus pyogenes.In Vitro Activity of AZD0914, a Novel Bacterial DNA Gyrase/Topoisomerase IV Inhibitor, against Clinically Relevant Gram-Positive and Fastidious Gram-Negative Pathogens.Molecular characterization of acquired enrofloxacin resistance in Mycoplasma synoviae field isolates.Multiclonal emergence of levofloxacin-resistant group B Streptococcus, Taiwan.First molecular characterization of fluoroquinolone resistance in Aerococcus spp.Assessment of antibiotic resistance in probiotic strain Lactobacillus brevis KB290.Emerging fluoroquinolone resistance in Streptococcus agalactiae in South Korea

P2860

Q33237073-40408003-CBC8-47C3-B35F-6E48028FF383 Q33587116-E938C98E-0313-4F8F-9623-F5AF3B064715 Q33703629-63C5551C-B192-4EF8-B622-4342BD939B96 Q33836671-D2235AF3-1473-48C0-9718-E25E40B53BAC Q34456975-8B8DECA5-F87A-4B4E-9829-5212C8DF387D Q34509660-2E18ABCD-4672-46F7-86D0-167576985695 Q35168877-E085F32C-27CB-4BF0-9E64-6C59CBAD2202 Q35188390-1DCE896B-429B-4E7E-B056-AA26608C9CA3 Q35636018-00BF7FC5-86B8-427B-B599-C7063EBDB8BF Q35642002-E4AD48FD-D1DE-4EB9-BBDC-FAE9BC63ECA2 Q35917434-48AEE889-5F65-4D34-BE0F-B2FE00227E12 Q36593828-B72DFF49-78D6-44CE-9842-FC707F66CBF0 Q36667222-5AEA21CA-26AE-4908-8BA9-1E78E1A92762 Q36993479-F666B295-24F1-4A6A-B5C2-9241A7F36290 Q37070478-EB1C2EF4-9727-45F1-827C-91656D831276 Q37159137-9941A8B2-E19B-44B8-8046-C5F69D52FE62 Q37204223-555403F6-D8F7-4D41-8E7C-E0CB2E053A56 Q37363399-7AE6C97A-1DAA-4F5D-A3A7-ABDDF0FC4B1F Q37428706-173A8695-5718-4D1B-9704-AC6D25D7B4D3 Q39455259-AC0912C2-F143-4F82-B111-3AF99347EF76 Q40334880-BDA9E293-D072-48F4-95CD-6D815BB588AF Q41098625-DCDC9290-06C6-4AD6-8BF2-7CBB134A6240 Q41442822-4F8755D3-F3BC-456C-90EB-F3268A7F7D75 Q41992960-99A5E3F9-BD33-4C29-B328-6DEC37632D35 Q42567173-1B1894A2-77EE-4CBC-9635-C178A9E8DB3F Q43272092-AB0CC9C3-5F9A-41C8-98C8-DB64563F2325 Q57213960-43E722A6-8237-4C7C-B8FA-D65794895BDF

P2860

First Streptococcus agalactiae isolates highly resistant to quinolones, with point mutations in gyrA and parC.

http://www.wikidata.org/entity/Q36880109

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

2003年论文

@zh

2003年论文

@zh-cn

name

First Streptococcus agalactiae ...... nt mutations in gyrA and parC.

@en

type

label

First Streptococcus agalactiae ...... nt mutations in gyrA and parC.

@en

prefLabel

First Streptococcus agalactiae ...... nt mutations in gyrA and parC.

@en

P1433

Q36880109-7BA9FFCD-786B-4EEF-B27B-19919257A04D

P1476

Q36880109-64B16767-BFCE-4EA8-AC30-AFDB031DCE4B

P2093

Q36880109-006061C1-327F-49FD-B3B7-13B97D0FD01A

Q36880109-09286983-DC24-4788-913A-39F9A9B889E4

Q36880109-5F4344F8-7D72-4974-9641-6C3AB81B141D

Q36880109-7A330021-F8A5-422D-8D1D-9A747003F451

Q36880109-99026101-861E-4899-9C9C-B2F1EF0D5FF3

Q36880109-9B2298E9-5D6C-49D5-BCF3-CD4F862F8CA5

Q36880109-C80F0BD4-311B-4478-967C-C43DC36E831F

Q36880109-DC5463A0-EAB7-4150-8213-9A6625B540FC

P2860

Q36880109-0C528CEA-4D22-430F-8710-A0629501526E

Q36880109-2F054986-8F6A-43CF-998C-3ADD0AF998CD

Q36880109-49DD1ADA-3AF2-4E20-B282-8FCEE13D45D0

Q36880109-5E37DE37-E658-4DC9-BE0C-5280FE710E57

Q36880109-8DB4FEEC-01C0-4CF3-8223-C5B8454CE589

Q36880109-955AF0D8-AF2B-4C6D-BBCB-CBFBABE5EB81

Q36880109-B6874B1E-4E02-4B6B-B1FE-340EAB56A033

Q36880109-C4EE12D7-8CAB-412A-91A5-0024F7C8B8F8

Q36880109-C623FC4C-F461-4F54-A90A-379246AE2EAF

Q36880109-D17FA500-F644-47B6-9279-C50502710AD9

P304

Q36880109-D553CF10-851A-468D-B5E7-C9FB8D3ACD2F

P31

Q36880109-C32D061D-12BF-4394-97BA-8A84B716A749

P356

Q36880109-C7206B20-6F1B-40FF-9BDE-7877D5A26986

P407

Q36880109-4E97E003-61A9-45D7-BC39-8098FC49D5F1

P433

Q36880109-1F3A2122-1AFA-476C-A75E-5D8AC946BF49

P478

Q36880109-78FF4BB9-B675-4E7C-86D8-6DEEC5D7F191

P577

Q36880109-AFF698EB-F396-44A2-8CD4-546C4DC5F903

P5875

Q36880109-90905330-793F-4597-90CA-709B64D32170

P698

Q36880109-C62EB6E9-40AD-421F-85F2-D36BC8799B45

P921

Q36880109-66E5A514-9FCE-4EC1-BBB6-3D47370A10A8

P932

Q36880109-870CDDC4-231F-4480-AC9B-F29E22877308

P356

AAC.47.11.3605-3609.2003

P1433

Antimicrobial Agents and Chemotherapy

P1476

First Streptococcus agalactiae ...... nt mutations in gyrA and parC.

@en

P2093

Ayako Tanimoto

http://www.w3.org/2001/XMLSchema#string

Hiromitsu Fujiwara

http://www.w3.org/2001/XMLSchema#string

Noriko Mishima

http://www.w3.org/2001/XMLSchema#string

Shiro Ikawa

http://www.w3.org/2001/XMLSchema#string

Takayuki Ezaki

http://www.w3.org/2001/XMLSchema#string

Yoshiaki Kawamura

http://www.w3.org/2001/XMLSchema#string

Youko Itoh

http://www.w3.org/2001/XMLSchema#string

Yuko Tanaka

http://www.w3.org/2001/XMLSchema#string

P2860

Improved tools for biological sequence comparison.

Activities of clinafloxacin, gatifloxacin, gemifloxacin, and trovafloxacin against recent clinical isolates of levofloxacin-resistant Streptococcus pneumoniae.

Resistance to multiple fluoroquinolones in a clinical isolate of Streptococcus pyogenes: identification of gyrA and parC and specification of point mutations associated with resistance

Activities of newer fluoroquinolones against Streptococcus pneumoniae clinical isolates including those with mutations in the gyrA, parC, and parE loci

Genetic analyses of mutations contributing to fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae

Antimicrobial susceptibilities of group B streptococci isolated from patients with invasive disease: 10-year perspective.

Fluoroquinolone resistance in Streptococcus pneumoniae in United States since 1994-1995.

Fluoroquinolone-resistant Streptococcus pneumoniae strains occur frequently in elderly patients in Japan

Superantigen-like gene(s) in human pathogenic Streptococcus dysgalactiae, subsp equisimilis: genomic localisation of the gene encoding streptococcal pyrogenic exotoxin G (speG(dys)).

Determination of 16S rRNA sequences of Streptococcus mitis and Streptococcus gordonii and phylogenetic relationships among members of the genus Streptococcus.

P304

3605-3609

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.47.11.3605-3609.2003

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

47

http://www.w3.org/2001/XMLSchema#string

P577

2003-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

231587506

http://www.w3.org/2001/XMLSchema#string

P698

14576126

http://www.w3.org/2001/XMLSchema#string

P921

P932

253773

http://www.w3.org/2001/XMLSchema#string